GLP-1 Agonists and Parkinson's Disease Neuroprotection
Diabetes drugs show promise in lab but fail to slow Parkinson's in patients.
Priya Costa
Senior Writer
Priya Costa is a senior writer at glpletter covering emerging glp-1 indications. Based in Amsterdam, Priya has written for glpletter since 2017.
1 story · Amsterdam
Diabetes drugs show promise in lab but fail to slow Parkinson's in patients.